Xavier Tillou

Full Professor of Urology. Head of Urology and Transplantation dpt. Transplant surgeon. PhD in immunology. FEBU #urology #transplant #Health #ehealth #education

[Katherine Henriquez @Kativonhe]

Dr Jay Raman @urojdr Hematuria Risk-based Evaluation & Indications for Markers #CAU25

[Yüksel Ürün @DrYukselUrun]

🚨 New publication alert!
💊Enzalutamide before ☢️¹⁷⁷Lu-PSMA-617 improves OS vs. abiraterone in mCRPC.
Stronger PSMA expression, better sequencing and survival!
@OncJournal @OncoAlert @APCCC_Lugano @coskunyazgann @hatice_bolek @nahit_sendur @drdeniztural @yekeduz_emre
https://t.co/E9tAo9BGwK

[Xavier Tillou @XTillou]

@LeducPh Je n’ai jamais bien compris le mode de calcul. Le gain en PIB, productivité, retour sur impôts sont ils inclus dans les revenus? La santé ne peut être financée de façon bénéficiaire puisque son but est entre autre de maintenir une nation en bonne santé et donc productive

[Xavier Tillou @XTillou]

Heureux de participer à nouveau à l’enseignement de l’#EFPMO, l’École Française du Prélèvement Multi-Organes.
Former, transmettre, s’engager pour le don et la transplantation d’organes.
Fier de contribuer à cette aventure humaine et médicale.
#Urologie #Transplantation #Médecine

[Xavier Tillou @XTillou]

🆕 Just published!
A narrative review on surgical techniques for living donor nephrectomy — from lumbotomy to robotic surgery 🤖
In Int. Urol. Nephrol.
👉 https://t.co/JMWDrhvVX5
#Transplantation #RoboticSurgery #Urology #LivingDonation

[Xavier Tillou @XTillou]

@VieDeCarabin C’est tout à fait ça….

[Xavier Tillou @XTillou]

@doclauravater I lost probably few years of life for staying up all night so many time

[The PhD Place @ThePhDPlace]

Qualitative researchers when they see statistics

[Xavier Tillou @XTillou]

Excellentes 1res Journées d’Actualités Normandes en Onco-Urologie – #JANOU2025 !
Toutes les nouveautés prostate, rein, vessie + grands changements 2025 (#CCAFU #ASCOGU).
Médecins, urologues, oncologues, radiothérapeutes réunis !
#OncoUrologie #Urologie #Oncologie #Normandie

[Adam B. Weiner, MD @Adam_Weiner535]

🚨TP vs TR prostate biopsy🚨

📜TRANSLATE RCT out in @TheLancetOncol

👉Transperineal biopsy...
1⃣More ≥GG2 #prostatecancer detected
2⃣Similar to possibly fewer infections WITHOUT any antibiotic prophylaxis

🔗https://t.co/hL1a0qUcfo

👏#EAU25 @LabBryant @LambAlastair @PCF_Science @PCFnews @urotoday @UrologyTimes @renalandurology @ZEROCancer

[Samuel Hume @DrSamuelBHume]

5. Results from the first pig-to-living human kidney transplant

To reduce the risk of rejection and to inactivate pig retroviruses, 69 edits to the pig's genome were made, with CRISPR

There was a challenging course post-surgery in this case, but this approach could massively broaden the supply of kidneys available for transplant

https://t.co/s4Fwx6vjlX

[Raffaele Di Giacomo, PhD @sciqst]

Advanced imaging techniques like PET PSMA are indeed revolutionizing how we classify and manage metastatic castration-sensitive prostate cancer (mCSPC). However, the challenge remains to translate these advancements into concrete therapeutic pathways. Clinical trials are essential to bridge this gap by assessing the impact on patient outcomes. Have there been any trials proposed, or is there a specific trial design you think would be beneficial? #Medicine #ProstateCancer. For a deeper dive into biomedical developments, check out https://t.co/4Y9Imt8uIJ. It's a one-stop platform for generating comprehensive reviews on all your biomedical questions.

Support Medical Doctors in Uganda: Help by sharing this GoFundMe! 🙏 ❤️ → https://t.co/SAKzlpV5k5

[Xavier Tillou @XTillou]

PET PSMA refining patients classification mCSPC #prostatecancer
But what to do with it? Need for clinical trials. #APCCCDiagnostics25 @OncoAlert

[OncoAlert @OncoAlert]

A warm invitation to JOIN US at #APCCCDiagnostics25 🇨🇭in Lugano A HYBRID Meeting (In Person & Live) Switzerland February 27-28, 2025

REGISTER: https://t.co/fatLEE5vtP

ONLINE REGISTRATION FOR LMIC's FREE
OncoAlert 🚨Will be Live in Lugano with Coverage🇨🇭

In recent years, diagnostic capabilities for Prostate #Cancer have significantly advanced through innovations in imaging, biomarkers, and the introduction of PSMA PET imaging, which have reshaped traditional diagnostic approaches. To address these advancements and their growing relevance in early detection, a new conference series, APCCC Diagnostics, will launch in February 2025 in Lugano, Switzerland, focusing on #ProstateCancer diagnostics.

@APCCC_Lugano

Scientific Committee
@ProfKHerrmann 🇩🇪
@stefanofanti4 🇮🇹
@Silke_Gillessen 🇨🇭
@AOmlin 🇨🇭

Ambassadors
@ZilliThomas 🇨🇭
@LoebStacy 🇺🇸
@nataliagandur 🇦🇷
@bavilima 🇧🇷
@fabioturco92 🇨🇭
@DrYukselUrun 🇹🇷
@weoncologists 🇺🇸

[Xavier Tillou @XTillou]

https://t.co/zeCDsoeoq0

[Xavier Tillou @XTillou]

@bruno_chaix @VieDeCarabin Bjr. En 1995 les syndicats d’étudiant en médecine dont je faisais parti avaient demandé à l’état l’augmentation impérative et progressive du numerus clausus pr anticiper le déclin démographique des médecins….ceux qui ont demandé son maintien doivent tous être en retraite….

[Xavier Tillou @XTillou]

World first. #robotic #cystectomy #neobladder #renaltransplant. Thanks 🙏🏻 to all the team for making it possible. https://t.co/oeuXzIKZqL

[Xavier Tillou @XTillou]

Challenging cases today 🤓#robotic level 2 vena cava thrombus #kidneycancer & posterior hilar #robotic partial nephrectomy. Thanks you Jean-Christophe Bernhard @uroccr for paving the way 🙏🏻 @WaeckelT @chu_caen